Choosing an Eye-Area Skin Booster — Separate the Concern and Depth Before the Product
The eye area is a spot with many questions in skin booster consultations. Because the skin is thinner than elsewhere on the face, amounts and particles that weren't noticeable on the cheeks can be felt or show through around the eyes. On top of that, the phrase “eye-area concern” mixes fine lines, hollowing and colour. This article separates those three first, then writes which booster to consider at which depth.
The short answer
Choosing an eye-area skin booster means first dividing eye-area concerns into fine lines · thin texture, hollowing (groove), and colour (dark circles), then deciding a formulation and depth that clump and show through less in thin skin. For fine lines · thin texture we first look at dermal injections with no or fine particles (CellREDM · Rejuran), while the shadow of an under-eye groove calls not for a booster but for hyaluronic acid filler placed deep. In a literature review of 830 people, under-eye filler placed on the periosteum showed almost no Tyndall (bluish show-through), while in shallower layers it exceeded 30%. Miso Clinic in Daegu (4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, +82-53-428-2700) doesn't use non-dissolvable CaHA under the eyes, and even when treating the whole face, we plan a reduced amount for the eye area from the start (clinical judgement).
How are eye-area concerns divided?
The single sentence “my eye area looks old” contains different problems. Different problems call for different treatments.
| Concern | What it looks like | Direction we look at first |
|---|---|---|
| Fine lines · thin texture | Fine lines that remain without smiling, a dry and thin feel | Dermal injection — CellREDM · Rejuran |
| Hollowing · groove (shadow) | A tired-looking under-eye groove that changes with light direction | Hyaluronic acid filler placed deep — not a booster's job |
| Colour (dark circles) | Brownish · bluish · mixed tones | By cause — often not solved by injections alone |
| Lines that deepen when smiling | Crow's-feet lines that appear with expression | The domain of botulinum toxin |
In the clinic we look with you sitting and lying down, and shine light from several directions. Shadows change with posture and light while pigment doesn't, so this alone separates hollowing from colour to a good extent (clinical judgement).
Why do particles and depth matter around the eyes?
The tissue covering the eye area is thin, so three things change.
- The same amount is easier to feel. An amount that looked natural on the cheeks surfaces around the eyes.
- It's easy to leave the layer. The target layer itself is shallow with no margin, so even slightly too shallow makes the surface look uneven.
- If particles are large or concentrate in one spot, clumps show as they are. If hyaluronic acid goes in too shallowly, light scatters and it shows bluish — the Tyndall effect.
There's data showing how much depth decides the result. In a literature review gathering 830 people with under-eye filler, placement on the periosteum showed almost no Tyndall, while in shallower layers it exceeded 30%. Even with the same product and amount, the result differs this much when the layer differs. So if only product names are exchanged at consultation, the planning hasn't started yet.
The often-quoted figure “eye-area skin is 0.5 mm” isn't used in this article because I couldn't confirm its primary source. Facial skin thickness itself varies greatly from person to person — in 3D measurement of 30 cadavers, skin was 2.1 ± 0.4 mm and superficial fat 5.2 ± 1.9 mm (Lee 2021; not values measured around the eyes alone).
How is each product judged for the eye area?
I couldn't confirm any study directly comparing boosters around the eyes. So the table below is Miso Clinic's judgement based on the nature of the formulation and confirmed data.
| Product (type) | Judgement for the eye area | Evidence and limits |
|---|---|---|
| CellREDM (hADM) | Look at first | Fine particles of about 75 μm (manufacturer's published figure). No published human trial of the product itself confirmed |
| Rejuran (PN) | Considered | Doesn't create volume. In 3D measurement of 28 people with eye-area wrinkles, wrinkles · texture · pores improved; no control group (Kim JH 2022) |
| Byryzn (cross-linked HA) | With caution | Too shallow causes Tyndall. On the other hand it can be reversed with hyaluronidase |
| Gouri (liquid PCL) | Planned with reduced amount or left out | No particles, but no reversing injection, and no eye-specific human data confirmed |
| Juvelook (PDLLA) | Depending on the area | One 10-person lower-eyelid pilot (Lin 2022); no controlled data confirmed |
| Radiesse · Dclassy (CaHA) | Not used under the eyes | An area prone to nodules; no dissolving agent for CaHA |
Rituo and CellREDM are in the same hADM line, but for thin areas such as around the eyes we tend to use the finer-particle one (clinical judgement). The difference between them is in CellREDM and Rituo in Daegu: how they differ. There's also 2026 literature covering the indications and limits of using hyaluronic acid and PN under the eyes (J Clin Med 2026).
Will a skin booster fill under-eye hollows?
No. Skin boosters aren't volume-filling treatments, so they can't fill the shadow of a groove. For under-eye grooves, hyaluronic acid filler has thicker data — a literature review gathering 23 studies · 2,048 people found satisfaction of 85–90%.
Korean data differ a little from Western data. In 3D CT of 107 Koreans, orbital rim height and area didn't change significantly with age (Jeon 2020). So rather than simply repeating the explanation “the bone melts away and it hollows,” we also look at shifts in the fat compartments and decide where to fill and where to leave (clinical judgement). Details are in Why under-eyes look hollow, and the lid-cheek groove.
Conversely, when under-eye fat bulges forward, simply covering it with filler can make it look more swollen, so we also mention a surgical consultation.
Do dark circles fade with skin boosters too?
Dark circles mostly don't have a single cause. In a study classifying 65 people, including with ultrasound, pigmented 5% · vascular 14% · structural 3% · mixed 78% (Huang 2014).
| Cause | Features | Approach |
|---|---|---|
| Structural (shadow) | Changes with posture · lighting | Filling the hollow — filler |
| Pigment | Brownish, unchanged when posture changes | Consultation for pigment treatment — not solved by injections |
| Vascular | Bluish or reddish tones showing through thin skin | If thin skin is also present, consider dermal injections |
| Mixed | A mix of the above (78%) | One at a time, starting with the largest component |
So we don't say a single “dark circle booster” will solve it. Miso Clinic doesn't have a melasma laser, so if pigment is the main cause, we tell you so and point you to other options.
What if Tyndall or clumping occurs?
The next step depends on what material was put in. So around the eyes, a record of what was put in is important.
- Tyndall from hyaluronic acid — can be dissolved and reversed with hyaluronidase (Byryzn and Tyndall).
- CaHA — no dissolving agent, so if nodules form they have to be dispersed or removed in steps. That's why we don't use it under the eyes from the start.
- PCL · PDLLA — no reversing injection. How nodules progress and what is done is set out in Nodules after treatment.
- If you've had something around the eyes before — tell us the product name and when. If you don't remember, it helps to check the records where you had it.
Severe pain during or right after injection, the skin turning white or purplish, or vision problems are rare but can be signs of a vascular complication. Tell us right away.
How is the amount for the eye area decided?
When placing boosters across the whole face, Miso Clinic doesn't divide the total equally by area. We plan to reduce the amount for the eye area from the start, or leave it out depending on condition (clinical judgement). “We'll put the remaining amount around your eyes” isn't a practice we use.
A smaller amount doesn't mean doing less for you; it means the area to cover is smaller. I couldn't confirm any human data showing results scale when only the amount is increased over the same area, and in thin areas increasing the amount actually becomes the reason it can be felt. More on eye-area amounts is in Eye-area skin boosters: why reduce the amount?. If you're curious about device treatment around the eyes, see XERF under the eyes too.
Eye-area skin boosters: frequently asked questions
Which skin booster suits fine lines around the eyes?
We first look at dermal injections with no or fine particles. Miso Clinic first considers CellREDM (hADM, particles of about 75 μm) or Rejuran (PN). There's no study comparing the two directly around the eyes, so we decide by skin thickness and sensitivity.
My under-eyes are hollow — will a skin booster fill them?
Skin boosters aren't volume-filling treatments and can't fill the shadow of a groove. For under-eye grooves, we first consider placing hyaluronic acid filler deep, such as on the periosteum.
Why does the area under my eyes look bluish?
It's the Tyndall effect, where hyaluronic acid placed shallowly scatters light. In a literature review of 830 people, placement on the periosteum showed almost no Tyndall while shallower layers exceeded 30%. It can be reversed with hyaluronidase.
Can I have Radiesse or Dclassy under the eyes?
Miso Clinic doesn't use CaHA under the eyes, because it's an area prone to nodules and there's no dissolving agent for CaHA.
Can dark circles be removed with injections?
Most have mixed causes (78% mixed in a 65-person study), so often a single injection doesn't solve it. The shadow component is approached by filling, and the pigment component with other treatment.
Where can I get an eye-area skin booster consultation in Daegu?
Miso Clinic in Daegu is at 4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, in front of Exit 1 of Kyungpook National University Hospital Station. +82-53-428-2700; weekdays 11:00–19:00 · Saturday 10:00–16:00 (no lunch break); closed Sundays · public holidays.
Clinical columns to read next
- Rejuran Eye in Daegu: what's different around the eyes?
- Skin boosters in Daegu: where to start
- Six skin boosters compared at a glance
- Eye-area · under-eye fine lines in Daegu — treatments to touch and to avoid
- Eye-area skin boosters: why reduce the amount?
- Why under-eyes look hollow, and the lid-cheek groove
- Skin that suits Rejuran
- Hyaluronidase — what can be reversed
- Vascular occlusion — a rare complication to know first
Product reference
Clinic
This column was written and reviewed by Lee Chi-Hak, MD, medical director of Miso Clinic in Daegu. The treatment criteria and injection design are written exactly as we actually use them.
| Medical Director | Lee Chi-Hak, MD |
|---|---|
| Address | 4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu (Exit 1, Kyungpook National University Hospital Station) · tower parking in the building |
| Phone | 053-428-2700 |
| KakaoTalk consultation | Miso Clinic Daegu channel |
| KakaoTalk channel | Add the channel |
| Opening hours | Weekdays 11:00–19:00 (lunch 13:00–14:00) / Saturday 10:00–16:00 (no lunch break) / Closed Sundays and public holidays |
| Clinical column | See all columns |
| Reference library | All booster and lifting device references |
References
- Evidence for under-eye filler — literature review of 23 studies · 2,048 people (satisfaction 85–90%) · literature review of 830 people (Tyndall almost 0 with periosteal placement, over 30% in shallower layers) · 3D CT of 107 Koreans (Jeon A et al., Surg Radiol Anat 2020;42(5):617 — no significant change in orbital rim height · area).
- Types of dark circles — Huang YL et al., Int J Dermatol 2014;53(2):164. 65 people classified — pigmented 5% · vascular 14% · structural 3% · mixed 78%.
- Under-eye HA and PN — Hyaluronic Acid Fillers Versus Polynucleotides for Under-Eye Rejuvenation, Journal of Clinical Medicine 2026. Literature covering indications and limits for use around the eyes.
- 3D measurement study of PN around the eyes — Kim JH et al., Aesthetic Plastic Surgery 2022;46(4):1902. PN injected for eye-area wrinkles, 30 enrolled · 28 completed · 18 weeks, Antera 3D measurement. Wrinkle grade p<0.001, wrinkles · texture · pores p<0.05, no change in melanin. A before-and-after design without a control group.
- CellREDM product information — made by Hans Biomed (Korean rights Hugel). hADM fine particles about 75 μm (manufacturer’s figure). We found no published human trial of CellREDM itself.
- Human data on PDLLA — 4 pilot studies: Seo 2024 (20 people, face) · Ma 2024 (10 people, back of hands, 3 sessions 3 months apart) · Lin 2022 (10 people, lower eyelid) · Seo 2024 (20 people, with CO₂ laser, stretch marks). Increased COL1A1 · COL3A1 expression in a mouse model. No published results of randomized controlled trials confirmed. The Korean product (Juvelook) contains non-cross-linked hyaluronic acid together with PDLLA.
- Byryzn product information — Hugel brand · made by ACROSS. Cross-linked hyaluronic acid + lidocaine 0.3%, two 1.1 mL syringes (box labelling). Medical device (biomaterial for tissue repair), intended use “temporary improvement of facial wrinkles in adults.” The approval number was not found in public sources; 62026-I10-23-2790 on promotional material is a medical advertising pre-review number.
- CaHA safety — Safety of Calcium Hydroxylapatite: A Review (2017), adverse-event analysis of 5,081 treatments — nodules were the most common. Management of Nodules Following CaHA Injection, Aesthetic Surgery Journal 2024 — stepwise management. There's no agent that dissolves CaHA.
- Individual variation in facial layer thickness — Lee KW et al., Clinical Anatomy 2021;34(7):1050–1058, PMID 33583088. 3D measurement of 30 fixed cadavers; skin 2.1 ± 0.4 mm, superficial fat 5.2 ± 1.9 mm.
- Korean medical advertising law — Medical Service Act Article 56(2), which prohibits testimonial advertising, comparison with other medical institutions and superlative claims.
- Miso Clinic clinical guidelines — criteria for indications, design by area, pre-treatment explanation and consent. The source of sentences marked “clinical judgement” in this column.
Everything in this column is general information and does not replace medical diagnosis or treatment. Effects and side effects vary with individual skin condition, age and underlying illness, and the same result is not guaranteed for everyone. Any decision to proceed should be made in an in-person consultation with a physician.